The affected products and recommendations for what to do with the devices below have not changed. This recall involves removing certain devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it.

Affected Product

The FDA is aware that Abiomed has issued a letter to affected customers recommending certain Impella Purge Cassettes and Impella RP Pump Sets be removed from where they are used or sold.

Affected devices:

Device Name

Product Code 

Serial Number

UDI-DI

Impella RP US Pump Set

004334

434937A

00813502011029

Purge Cassette, 5 Pack

0043-0003

N/A

00813502011135

What to Do

Identify and remove all Generation 1 Purge Cassettes from use. If a Generation 2 Purge Cassette is not available and the use of a Generation 1 Purge Cassette is absolutely necessary, ensure increased monitoring of the Purge System and refer to the IFU if a “Purge Pressure Low” alarm is triggered.

On February 18, 2026, Abiomed sent all affected customers a letter recommending the following actions:

  • Review all Purge Cassettes (both individually packaged and within Impella RP Pump Sets) in inventory and if any Purge Cassettes are identified as impacted, please set aside and quarantine.
  • If impacted product is identified, utilize the return shipment label provided by Abiomed to initiate the return.
  • Follow your standard process to order Generation 2 Purge Cassettes
    • Use of a Purge Cassette is always required when using an Impella Pump. If a Generation 2 Purge Cassette is not available to you and the use of a Generation 1 Purge Cassette is absolutely necessary, you may continue to use it. However, ensure increased monitoring of the Purge System and refer to the IFU if a “Purge Pressure Low” alarm is triggered.
  • Forward this notice to anyone in your facility that needs to be informed (i.e., those who manage, transport, store, stock, or use the subject products).
  • If any of the subject products have been forwarded to another facility, contact that facility and provide them with this notice.
  • Post a copy of this notice in a visible area for awareness.

Reason for Recall

Abiomed, Inc. has reported that Generation 1 Purge Cassettes have an increased risk of purge leaks. As a result, Abiomed is removing Generation 1 Purge Cassettes in markets where updated Generation 2 Purge Cassettes are available.

If a Purge Cassette leak were to occur, the user would see a “Purge Pressure Low” alarm on the Automated Impella Controller (AIC); see example of alarm below:

 

A purge leak may lead to low purge pressure if it goes unaddressed. This can lead to biomaterial ingress, which may lead to an unexpected pump stop. A pump stop may result in a loss of hemodynamic support and lead to patient death.

As of February 3, Abiomed has reported four serious injuries and no deaths associated with this issue.

Device Use

The purge cassette delivers rinsing fluid to the Impella catheter. The purge fluid flows from the purge cassette through the catheter to the microaxial blood pump to prevent blood from entering the motor.

Contact Information

Customers in the U.S. with adverse reactions, quality problems, or questions about this issue should contact Abiomed at OneMD-Field-Actions@its.jnj.com.

Additional FDA Resources

Unique Device Identifier (UDI)  

The unique device identifier (UDI) helps identify individual medical devices sold in the United States from manufacturing through distribution to patient use. The UDI allows for more accurate reporting, reviewing, and analyzing of adverse event reports so that devices can be identified, and problems potentially corrected more quickly.  

How do I report a problem?

Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program.

Timeline of Communication Updates

Date Actions
04/03/2026 The FDA updated this communication to inform the public that this issue has been classified as a Class I Recall.
02/25/2026 The FDA issued an Early Alert communication to notify the public of a potentially high-risk device issue.

  • Content current as of:

    04/03/2026

Source

Clinical :: Oncology :: Nuclear :: Geriatric :: Regulatory :: Technology :: Consulting

"My passion is helping businesses, small and large, perform at their best." - Felicia Udoji-Eddings, Pharm.D.

Dr. Felicia Udoji-Eddings is the Founder and CEO of The Health Pals Company, a vertically integrated Healthcare System. As an experienced Clinical Pharmacy Leader, Pharmacy Consultant, Healthcare Executive, and Licensed Pharmacy Practitioner with deep backgrounds in Information Technology (IT), Scientific Research, and Business Management. Dr. Udoji-Eddings has a strong track record of exceptional performance in different business environments. A skilled Business Strategist, Dr. Udoji-Eddings has tackled complex problems and helped several organizations refocus their strategy in tough economic times. As a highly motivated and proactive individual, Felicia enjoys working with teams, in various capacities, to facilitate positive outcomes.